{"id":"W4410815036","doi":"10.1200/jco.2025.43.16_suppl.4013","title":"Long-term outcomes and overall survival (OS) for zanidatamab + chemotherapy in HER2-positive (HER2+) advanced or metastatic gastroesophageal adenocarcinoma (mGEA): 4-year follow-up of a phase 2 trial.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Jazz Pharmaceuticals","keywords":"Medicine; Chemotherapy; Internal medicine; Gastroesophageal Junction; Overall survival; Oncology; Metastatic adenocarcinoma; Adenocarcinoma; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003381179,0.0006728515,0.0009313524,0.000292726,0.0003852087,0.0008000924,0.0005606715,0.0010592,0.002367883],"category_scores_gemma":[0.00134867,0.0002825282,0.001306901,0.0002992892,0.0006175693,0.0007216058,0.0004285286,0.001829121,0.0004771174],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001022633,"about_ca_system_score_gemma":0.0009168762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006625689,"about_ca_topic_score_gemma":0.00152993,"domain_scores_codex":[0.9993493,0.0003479214,0.00004256125,0.00008344747,0.00006391053,0.0001129639],"domain_scores_gemma":[0.9989867,0.0001767327,0.0003730685,0.00009124268,0.00005073144,0.0003215107],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8757712,0.02095799,0.03787034,0.0004791019,0.002264622,0.0001310562,0.000148698,0.001621364,0.008385473,0.00008532414,0.002219707,0.0500652],"study_design_scores_gemma":[0.3358599,0.5024236,0.1481556,0.0001092544,0.003202996,0.0004366628,0.0001015873,0.001642878,0.003954945,0.0002945279,0.003771103,0.00004693887],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956703,0.00180374,0.0001684383,0.0001616878,0.00003764989,0.0005592594,0.0008425065,0.00001662319,0.0007398723],"genre_scores_gemma":[0.9941223,0.0008092495,0.0003708305,0.0003991058,0.00008678515,0.0008203957,0.002400896,0.000008605424,0.0009818884],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003381179,"threshold_uncertainty_score":0.01788157,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09468660590871203,"score_gpt":0.4711726015739391,"score_spread":0.3764859956652271,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}